James Brugarolas

24PUBLICATIONS
213CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Electrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 17, 2026
A single chromosome 3p break initiates clear cell renal cell carcinoma evolution.

|Jun 08, 2026
Lactate-Activated GPR132 Signaling Drives a Tumor Microenvironmental Autocrine Metabolic Loop in Kidney Cancer.

|Apr 01, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Jing Han Hong, Chern Han Yong, Hong Lee Heng

|Oct 09, 2025
HIF-2-Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma.

Arijit Mal, Bingqing Xie, Zane Gray

|Jun 11, 2025
Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis.

Dylan Calhoon, Lingjie Sang, Fubo Ji

|Mar 18, 2025
Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial.

Jay Jasti, Hua Zhong, Vandana Panwar

Pageof 4

Frequent Collaborators

11 joint publications

Payal Kapur

9 joint publications

Vanina Toffessi-Tcheuyap

4 joint publications

Alana Christie

3 joint publications

Xiankai Sun